Physician profile
Corbin D Sullivan
NPI 1225352792
$1,557.51
in general payments reported to CMS, 2019-2025
22 companies · $251 in 2025
The $251 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $217 · 2020: $143 · 2021: $125 · 2022: $225 · 2023: $175 · 2024: $422 · 2025: $251.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $848.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $848.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $359.90 | 2019-2025 | Medline Industries, INC., Xpress Ent Dilation System, Audion Et Dilation System |
| Cochlear Americas | $335.56 | 2024-2025 | Osia Osi300 Implant, Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode |
| Integra Lifesciences Corporation | $139.53 | 2020-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Intersect Ent, INC. | $109.45 | 2020-2021 | |
| Acclarent, INC | $72.05 | 2019-2023 | Inspira Air, Acclarent Aera |
| Genzyme Corporation | $71.32 | 2019-2024 | |
| Glaxosmithkline, LLC. | $69.86 | 2022-2025 | Nucala |
| Novartis Pharmaceuticals Corporation | $45.99 | 2019 | |
| Optinose US, INC. | $42.79 | 2019-2020 | |
| Aerin Medical INC. | $41.97 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $35.48 | 2021-2022 | |
| Hologic Sales and Service, LLC | $32.62 | 2023 | Coolseal Generator |
| Karl Storz Endoscopy-America | $26.86 | 2021 | |
| Phadia US INC. | $24.67 | 2021-2024 | Immunocap |
| Medtronic USA, INC. | $24.65 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $23.76 | 2020 | |
| Precigen, INC. | $22.80 | 2025 | |
| Merck Sharp & Dohme LLC | $21.13 | 2023 | |
| Medtronic, INC. | $16.57 | 2022 | |
| Baxter Healthcare | $14.66 | 2019 | |
| Olympus America INC. | $13.49 | 2019 | |
| Arbor Pharmaceuticals, INC. | $12.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Corbin Sullivan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.